Perindopril Substudy in Coronary Artery Disease and Diabetes: the Diabetic Substudy of EUROPA - PERSUADE


The goal of the study was to evaluate the effect of treatment with the angiotensin-converting enzyme (ACE) inhibitor perindopril compared with placebo on cardiovascular (CV) events in the diabetic and nondiabetic subgroups of patients with stable coronary artery disease (CAD) in the EUROPA trial.